butabarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Coadministration of CYP3A4 inducers could minimize sufentanil amounts and efficacy, possibly precipitating withdrawal syndrome in patients who may have created physical dependence to sufentanil. Discontinuation o